Related Experiment Video

Updated: May 13, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

[Diagnosis and treatment of hypertrophic cardiomyopathies]

C Kühl1, M Luedde, C Langer

  • 1Innere Medizin III, Kardiologie und Angiologie, Universitätsklinikum Schleswig Holstein, Campus Kiel.

Deutsche Medizinische Wochenschrift (1946)
|March 14, 2013
PubMed

Insights

Hypertrophic cardiomyopathy, a common inherited heart disease, affects 0.2% of people. Diagnosis involves ECG, echocardiography, and advanced imaging for risk stratification, with treatments ranging from medication to surgical interventions.

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Context:

  • Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited cardiac condition, affecting approximately 0.2% of the population.
  • A significant portion of HCM patients (two-thirds) develop left ventricular outflow tract obstruction, impacting clinical presentation and management.
  • Typical symptoms include angina, dyspnea, syncope, heart failure, and atrial fibrillation, necessitating comprehensive diagnostic evaluation.

Purpose:

  • To outline the prevalence, clinical features, diagnostic approaches, and therapeutic strategies for hypertrophic cardiomyopathy.
  • To emphasize the importance of routine diagnostic tools like ECG, Holter monitoring, and exercise testing for risk stratification and identifying adverse clinical courses.
  • To highlight the role of advanced imaging, such as Cardiac MRI, in assessing risk for sudden cardiac death and guiding decisions on implantable cardioverter-defibrillator (ICD) implantation.

Summary:

  • HCM diagnosis relies on ECG, echocardiography, Holter monitoring, and exercise testing to identify risk factors and disease progression.
  • Cardiac MRI serves as a crucial complementary tool for risk stratification, particularly for sudden cardiac death and ICD candidacy.
  • Conservative management includes beta-blockers, with emerging pharmacological options anticipated. For symptomatic patients with outflow tract obstruction, septum-reducing therapies like surgical myectomy or transcatheter alcohol septal ablation are effective.

Impact:

  • Improved diagnostic accuracy and risk stratification for HCM patients, leading to more personalized treatment plans.
  • Enhanced management strategies for symptomatic individuals with left ventricular outflow tract obstruction, potentially improving quality of life.
  • Provides a foundation for future research into novel pharmacological therapies and refined interventional techniques for HCM.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...